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Infection with some helminth pathogens represents a biological
carcinogen
Infectious diseases cause more than 20% of cancers in the developing world [1]. About a
dozen pathogens including Epstein-Barr virus and human T cell lymphocytotropic virus 1
are among the well-known examples. In addition, infection with several trematodes, which
are eukaryotes, can cause malignancy. The International Agency for Research on Cancer categorizes infection with the fish-borne trematodes Opisthorchis viverrini and Clonorchis sinensis and the blood fluke Schistosoma haematobium as Group 1 biological carcinogens [2]. In
addition to parasitism directly damaging development, health, and prosperity of infected
populations, infection with these helminths leads to cholangiocarcinoma (CCA) (bile duct
cancer) and squamous cell carcinoma (SCC) of the urinary bladder, respectively [2]. By contrast, infection with phylogenetic relatives, also trematodes of the phylum Platyhelminthes
and also major pathogens, is not carcinogenic. These irregularities suggest that either helminth-specific metabolites contribute to tumorigenesis and/or that certain tissues or organs
are particularly susceptible to infection-induced malignancy. Moreover, each of these helminth infections must be viewed holistically in the context of a perfect storm of risk for cancer (see [3]).

Helminth infection–induced cancers
O. viverrini and C. sinensis infection–induced cholangiocarcinoma
Infection is accomplished by ingestion of undercooked freshwater fish infected with the metacercaria stage of these species of liver flukes. Human infection leads to hepatobiliary disease,
including cholangitis and periductal fibrosis. In liver fluke–endemic regions, infection is the
major risk factor for CCA [2, 4, 5]. CCAs are slow-growing adenocarcinomas that metastasize
to distant sites due to proximity to lymphatic vessels. Liver fluke–related CCA is often diagnosed at an advanced stage, when the primary cancer is no longer amenable to curative surgery
[5]. The mechanism(s) by which infection initiates genetic lesions that eventually culminate in
CCA is not understood, although it is likely to be multifactorial, involving biliary tract and systemic chronic inflammation and associated endogenous nitrosation [6, 7], secretion of mitogens and other mediators by the parasite, and cofactors including dietary preferences for
nitrosamines-rich foods [4, 8, 9] (Fig 1).
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Fig 1. Schematic representation of hypothesized processes of carcinogenesis of the biliary tract and urinary bladder during chronic
infection with fish-borne liver flukes Opisthorchis viverrini (Ov) and Clonorchis sinensis (Cs) and the blood fluke Schistosoma
haematobium (Sh). Photomicrographs: adult developmental stages of Cs and Ov and the egg stage of Sh. During infection, mutations initiate
carcinogenesis, perhaps as the consequence of interaction of epithelial cell chromosomal DNA with inflammation-associated reactive oxygen species
(ROS) and reactive nitrogen species (RNS) and lipid peroxidation and/or metabolites released by the worms, such as catechol estrogen quinones and
oxysterols. Subsequently, mediators of helminth origin such as granulin from Ov promote epidermal to mesenchymal transition (EMT), transformed cell
growth, complementary angiogenesis, down-regulation of apoptosis, and other hallmarks of cancer.
https://doi.org/10.1371/journal.ppat.1006393.g001

Urogenital schistosomiasis and bladder cancer
Three major species of schistosomes are the agents of schistosomiasis: S. japonicum and S.
mansoni cause intestinal schistosomiasis whereas S. haematobium causes urogenital schistosomiasis. Of about 112 million cases of S. haematobium infection in sub-Saharan Africa, 70 million are associated with hematuria, 18 million with major bladder wall pathology, and 10
million with hydronephrosis leading to kidney damage. Deposition of ova of S. haematobium
in the bladder wall can lead to SCC of the bladder [2, 10].

Initiation, promotion, and progression of tumorigenesis
Where opisthorchiasis is endemic, people can remain infected for decades. Opisthorchiasis
provokes inflammation of the biliary tree, with hyperplasia and metaplasia of the cholangiocytes that line the biliary tract adjacent to the flukes. Opisthorchiasis-induced fibrosis engulfs
the proliferating cells, manifesting as biliary periductal fibrosis [4, 11]. Chronic inflammation
in response to parasite metabolites and growth factors is implicated in the inflammatory
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response linked with infection [11]. Additional factors including carriage of Helicobacter and
other microbiome changes within the biliary tract might participate [8, 12]. Elevated plasma
interleukin-6 (IL-6) is associated with marked increase in risk of periductal fibrosis during
opisthorchiasis and compounds pathogenesis by promoting a fibrogenic inflammatory milieu.
The cell of origin of CCA is the cholangiocyte, a specialized epithelial cell that lines the bile
duct. Following initiation, for example by oxidation of cholangiocyte chromosomal DNA by
oxysterols generated by reactive oxygen species (ROS) and reactive nitrogen species (RNS)
arising during opisthorchiasis-induced oxidative stress [13] and/or oxysterols released by the
liver fluke [8, 14], oncogenesis appears to be promoted by cholestasis and chronic inflammation. The release and downstream consequences of IL-6, platelet-derived growth factor, tumor
necrosis factor-alpha (TNF-α), and transforming growth factor-beta (TGF-β) are pivotal to the
proliferation of cholangiocytes. Autonomous proliferation, evasion of apoptosis, and angiogenesis sustain the incipient neoplasm [11].
Bladder cancer is the most common tumor of the urinary system and consists of 2 main
forms—urothelial carcinoma (UCC) and SCC. The bladder is lined by a specialized epithelium
termed the urothelium, which is exposed routinely to potential carcinogens and hence is at
particular risk of cancer. The urothelium is a stratified epithelium composed of keratin 5 (K5)expressing basal cells, intermediate cells, and umbrella cells. K5-positive basal cells likely give
rise to SCC [10, 15–17]. UCC accounts for around 90% of bladder cancers, and major risk factors include tobacco smoking, occupational exposure to aromatic amines and polycyclic
hydrocarbons, and bladder stones, among others [10, 15]. In regions endemic for urogenital
schistosomiasis, SCC is more common than UCC and may be the cancer of highest incidence
[2, 10].
Schistosome eggs entrapped in the bladder wall release metabolites, presumably to facilitate
egress of the egg to the lumen and to the external environment. The process leads to hematuria
and to chronic inflammation, in turn increasing the risk of urothelial hyperplasia, dysplasia,
and SCC (Fig 1). Urogenital schistosomiasis (UGS) is a chronic infection, often interrupted by
drug treatment and often followed in turn by reinfection. Fibrosis induced by entrapped schistosome eggs may promote cellular proliferation, hyperplasia, and metaplasia that eventually
induce carcinogenesis [10]. Mass spectrometric analysis of urine during UGS reveals estrogenlike metabolites including catechol estrogen quinones (CEQ), likely of schistosome origin,
CEQ-DNA adducts, and novel metabolites derived from 8-oxo-7, 8-dihydro-20 -deoxyguanosine (8-oxodG) [18]. Nitrosamines and increased levels of beta-glucuronidase and cyclooxygenase-2 derived from schistosomes also represent potential bladder carcinogens. These
helminth infection–derived carcinogens may damage DNA, leading to somatic mutations in
oncogenes such as p53, retinoblastoma protein, epidermal growth factor receptor, and erbB2
receptor tyrosine kinase. In like fashion, chromosomal adducts including 8-oxodG and
8-nitroguanine and lipid peroxide-DNA increase during opisthorchiasis (see [19]).
Investigation of UGS-induced bladder cancer is challenging given that rodent models do
not exhibit urogenital disease; infection with S. haematobium causes hepatointestinal disease
in rodents. However, in a recently developed rodent model, eggs of S. haematobium injected
into the bladder wall of mice provoke egg-associated pathogenesis more reflective of the
human condition [20, 21]. Preneoplastic lesions involving epithelial to mesenchymal (EMT)like profiles have been described in this model following coadministration of exogenous nitrosamines [22]. These approaches might lead to deeper understanding of the carcinogenesis of
UGS-induced SCC. A hamster model involving coadministration of nitroso compounds and
liver fluke infection has long been employed to study infection-induced bile duct cancer [2, 4,
11, 19, 23]. Curiously, among the human schistosomes, only infection with S. haematobium is
categorized as a biological carcinogen [2]. Perhaps local levels of metabolites such as CEQ are
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not produced by S. mansoni and S. japonicum and/or the hepatointestinal niche of these intestinal disease–causing schistosomes is less disposed to schistosome infection–induced
malignancy.

Mutations, mutational signatures, rearrangements, epigenetics
Cancer arises when mutations occur in the DNA of the genome of the target cell and the mutations lead to uncontrolled cellular proliferation, invasion, and metastasis. The landscape of
mutations that accumulate within the tumor record the mutagenic processes that have taken
place over the life span of the malignancy. Each mutation endows an imprint on the genome
of the tumor, documenting the types of DNA lesion and repair processes that lead to base substitutions, insertions, deletions, and structural variations. These mutational profiles have
implications for diagnosis, therapy, and public health interventions.
Metabolites of helminth origin, including oxysterols, catechol estrogens, heme from
ingested blood, and others, all of which are reactive species, may depurinate host cell DNA,
leading to error-prone repair that results in mutations of cancer driver genes [8, 18]. At the
genomic level, analysis of the mutation profiles of O. viverrini–related versus nonliver fluke–
induced CCA reveals marked variation in mutation patterns [24]. Somatic mutations occur
frequently in the tumor suppressor genes p53 and smad4 in O. viverrini–induced CCA. By contrast, somatic mutations in the genes encoding BRCA1 associated protein-1 and isocitrate
dehydrogenases 1 and 2 are more common in non-O. viverrini–associated CCA [24, 25].
Mutations in p53 and smad4 directly affect the p53- and TGF-signaling pathways, both of
which are involved in tumorigenesis. Thus, distinct causes of CCA induce discrete somatic
alterations, even within the same cancer type [25]. Emphasizing this point, liver fluke infection–induced CCA exhibits altered DNA methylation and transcriptional profiles reflective of
xenobiotic metabolism and pro-inflammatory responses in comparison to nonliver fluke
infection–induced CAA and to healthy biliary duct [24–26].
Details also have emerged from whole exome sequences of UCC, although the specific
mutational landscape of SCC and hence UGS-induced SCC have not been reported [2, 15].
Mutation of sonic hedgehog can initiate carcinogenesis in bladder cancer [16]. Recurrent
mutations occur in >30 other genes involved in cell proliferation, differentiation, genetic stability, and specifically cell-cycle regulation, chromatin regulation, and kinase signaling pathways [27]. Bladder cancer frequently exhibits C to T or C to G mutations at TC dinucleotides,
which may reflect hyperactive DNA editing by apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like (APOBEC) cytidine deaminases [28].

Host–parasite interactions
Communication between helminths and host cells likely evolved to facilitate parasitism. Communicating metabolites may, however, contribute to carcinogenesis [8, 29]. For example,
O. viverrini secretes a growth factor termed Ov-GRN-1 that shares homology with human
granulin [30]. Secreted Ov-GRN-1 may promote angiogenesis and also wound repair of the
bile ducts damaged by the liver fluke [11, 30] (Fig 2). Moreover, Ov-GRN-1 may mimic the
action of interleukin-33 (IL-33), an epithelial mitogen for cholangiocytes, in the development
of CCA [31]. IL-33 primes type 2 innate lymphoid cells to induce proliferation of neighboring
cholangiocytes by the release of Interleukin-13 (IL-13). Antibodies to Ov-GRN-1 blocked its
ability to drive proliferation of host cells [30, 32]. Liver flukes also secrete extracellular vesicles
(EVs) [33] (Fig 1). The membranes surrounding EVs are enriched in tetraspanins, proteins
that interact with transmembrane and cytosolic signaling proteins [34]. Cholangiocytes internalize both O. viverrini EVs and Ov-GRN-1 [32]. Antibodies to a tetraspanin located on the
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Fig 2. Liver fluke granulin promotes wound repair and angiogenesis. Opisthorchis viverrini secretes a
growth factor termed liver fluke granulin, Ov-GRN-1, an orthologue of mammalian granulin. Ov-GRN-1
stimulates cholangiocytes to proliferate and promotes wound healing and angiogenesis. A recent report on
Ov-GRN-1 [32] illustrates some of these carcinogenic-conducive properties of the growth factor, as follows:
(A) rate of wound closure on a cutaneous lesion on mice, (B) the angiogenic nature of Ov-GRN-1 revealed
using the chorioallantoic membrane assay in fertilized quail eggs.
https://doi.org/10.1371/journal.ppat.1006393.g002

surface of O. viverrini EVs block the internalization by cholangiocytes of liver fluke EVs and
suppress the proliferation and secretion of IL-6 by cholangiocytes [33]. Other helminth proteins induce changes that reflect the hallmarks of cancer, including EMT phenotypes, proinflammatory cytokines, and repression of apoptosis [32, 35]. Type 2 T helper cell (Th2)
responses induced by schistosome proteins including interleukin 4-inducing principle of
schistosome eggs (IPSE) not only facilitate egress of the schistosome egg to the bladder lumen
by modulating the granuloma but also appear to modulate vasculogenic and cellular responses
conducive to neoplasia [10, 36]. Targeting these or other parasite–host cell communicating
proteins with vaccines may not only block helminth infections but deliver novel anticancer
vaccines [11].
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